Mexico fans can make the difference at Azteca vs. Ecuador - Aguirre

Mexico manager Javier Aguirre said he hopes local fans will make the difference for El Tri when the World Cup co-hosts face ...

So Ji-sub on his dramatically different looks before and after a project: "I tried to make the difference even bigger on purpose, and it was fun"

Sportschosun Kim So-hee] Actor So Ji-sub shared his candid thoughts on the much-talked-about difference in his appearance before and after a project.
Interesting Engineering on MSN

Why ballistic missiles and cruise missiles are not built for the same war

Missiles are often discussed as if they belong to a single broad category, but ...
Asharq Al-Awsat on MSN

Lebanon Enters Conflict Management Phase as End Remains Elusive

Beirut: Negotiations to cement the ceasefire in southern Lebanon, alongside talks on the future of the south, the role of the ...

Lexeo Therapeutics, Inc. (LXEO) Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia Transcript

Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia June 29, 2026 2:00 PM ...

MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder

The IRIS Phase 2 trial did not meet its primary endpoint in social communication deficits associated with ASDA prespecified analysis in ...

Have England qualified for World Cup 2026 knockout phase?

World Cup 2026: Have England qualified for knockout phase? - England’s final ranking in Group L is still to be determined ...

BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia

Phase 3 PROPEL 3 data published today in NEJM were simultaneously presented at ICCBH in a late-breaking oral presentation; presentation ...
Rutland Herald

Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

Ascendis Pharma: 5-Year Phase 2 Data Show TransCon PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism

Multi-organ system and quality-of-life benefits sustained through five years of treatment - 82% response rate for the multi-component endpoint - 95% of patients completed five years of treatment COPEN ...

Neurogene Inc. (NGNE) Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome Transcript

Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome June 29, 2026 8:00 AM EDTCompany ParticipantsLina ...

World Cup 2026: Why Austria may prefer to lose their final World Cup Group J game against Algeria

Austria are currently second in Group J, ahead of third-placed Algeria on goal difference; the teams meet in the final group game with Argentina already assured of top spot and Jordan eliminated; Aust ...